ÄúµÄµ±Ç°Î»ÖãºÊÓÍøÄ¤³öѪ > ÍøÄ¤³öѪԤ·À > 201606ÌÇÄò²¡»Æ°ßȱѪÓëÉî²ãÊÓ
201606ÌÇÄò²¡»Æ°ßȱѪÓëÉî²ãÊÓ
Ì⣺ÌÇÄò²¡»Æ°ßȱѪ°é¹â¸ÐÊÜÆ÷ËðÉËÓëÉî²ãÊÓÍøÄ¤Ã«Ï¸Ñª¹ÜÎÞ¹à×¢Ïà¹Ø£¨Ó¢ÎÄÌ⣺DeepRetinalCapillaryNon-perfusionisAssociatedwithPhotoreceptorDisruptioninDiabeticMacularIschemia£»×÷ÕߣºFabioScarinciµÈ£»×÷Õßµ¥Î»£ºÃÀ¹úÖ¥¼Ó¸çÎ÷±±´óѧ·Ñ¶÷²®¸ñҽѧԺÑÛ¿Æ£©»Æ°ßѪ¹©ÏµÍ³ÓÉÈý¸öÏ໥Á¬½áµÄëϸѪ¹Ü´Ô×é³É£¬±í²ãëϸѪ¹Ü´Ô£¨SCP£©·Ö²¼ÔÚÊÓÍøÄ¤Éñ¾ÏËά²ã£¬Öмä²ã£¨MCP£©ºÍÉî²ã£¨DCP£©·Ö±ð·Ö²¼ÔÚÄں˲ãµÄÄÚ²àºÍÍâ²à¡£¶ø»Æ°ßÖÐÐݼÎÞѪ¹ÜÇø£¨FAZ£©ºÍÍâ²ãÊÓÍøÄ¤²»ÓÉÕâÈý´ÔѪ¹Ü¹©Ñª£¬ËüÃǵÄÑõ¹©À´Ô´ÓÚÂöÂçĤѻ·¡£ÓÐʵÑéÑо¿±íÃ÷DCPÌṩ¹â¸ÐÊÜÆ÷ÄÚ²ã10-15%µÄÑõ¹©£¬ÓÈÆäÔÚ°µÊÊӦʱ¡£¸üÖØÒªµÄÊÇ£¬×îеÄÑо¿±íÃ÷µ±×é֯ȱÑõʱ£¬ÂöÂçĤѪ¹Ü²»ÄÜͨ¹ý×ÔÎÒµ÷½Ú¸ø×éÖ¯¹©Ñõ£¬Íâ²ãÊÓÍøÄ¤Ð³´úлËùÐèÑõ·ÖÓÉÄÚ²ãÊÓÍøÄ¤Ñª¹Ü¹©¸ø¡£Óɴ˲úÉúÒ»¸öÎÊÌ⣬ÌÇÄò²¡ÊÓÍøÄ¤²¡±äʱÂöÂçĤѪ¹©ÊÇ·ñÄܹ»²¹³¥ÊÓÍøÄ¤Ã«Ï¸Ñª¹ÜȱѪ£¿´ËÍ⣬¿¼Âǵ½ÌÇÄò²¡ÂöÂçĤ²¡±äÒÔ¼°×ÔÎÒµ÷½ÚɥʧµÄ¿ÉÄÜÐÔ£¬¹â¸ÐÊÜÆ÷ϸ°û½«´¦ÓÚÂýÐÔ¡¢ÍêȫȱѪµÄ״̬¡£ÎªÁËÑéÖ¤Õâ¸ö¼Ù˵£¬×÷ÕßʹÓÃSD-OCT¹Û²ìµ½ÌÇÄò²¡ÊÓÍøÄ¤Ã«Ï¸Ñª¹ÜÎÞ¹à×¢ÓëÍâ²ãÊÓÍøÄ¤½á¹¹ÖжÏÓйأ¬ÓÉ´ËÌá³ö»¼ÕßDCPµÄÎÞ¹à×¢ÄܽâÊÍÍâ²ãÊÓÍøÄ¤½á¹¹µÄ¸Ä±äÕâÒ»¼Ù˵¡£SD-OCT×îÐÂÍÆ³öµÄѪ¹ÜÔìÓ°ÊõÄÜ·ÇÇÖÈëÐÔ¹Û²ìѪҺÁ÷¶¯µÄÈýά½á¹¹£¬°üÀ¨SCP¡¢DCPºÍÂöÂçĤȱѪ¡£×î½üµÄÒ»ÏîÑо¿±íÃ÷Ѫ¹ÜÔìÓ°Êõ¿ÉÒÔÓÃÓÚ¹Û²ìÌÇÄò²¡ÊÓÍøÄ¤²¡±äµÄÒ쳣Ѫ¹Ü£¬°üÀ¨ÐÂÉúѪ¹Ü¡¢Î¢Ð¡¶¯ÂöÁö¡¢ÊÓÍøÄ¤Ã«Ï¸Ñª¹ÜÎÞ¹à×¢µÈ¡£´ËÏîǰհÐÔÑо¿ÄÉÈë10ÀýÌÇÄò²¡ÊÓÍøÄ¤²¡±ä»¼Õß14Ö»ÑÛ£¬SD-OCTÁªºÏOCTA¹Û²ìÍâ²ãÊÓÍøÄ¤¸Ä±ä£¬SCP»òDCPµÄëϸѪ¹ÜÎÞ¹à×¢ÇøÓò¡£Óɲ»Í¬¼ì²éÕß·Ö±ðÆÀ¹ÀSD-OCTɨÃè½á¹û£¬Ñª¹ÜÔìÓ°½á¹ûÅж¨ÊÇ·ñ´æÔÚëϸѪ¹ÜÎÞ¹à×¢¡£½á¹ûÏÔʾ£¬8ÑÛSD-OCTÏÔʾÍâ²ãÊÓÍøÄ¤½á¹¹Öжϣ¬°éÓлưßÖÐÐݼÎÞѪ¹ÜÇøÀ©´ó£¬DCPµÄëϸѪ¹ÜºÍѪ¹ÜÎÞ¹à×¢Çø¼äÎÞѪҺÁ÷¶¯·¶Î§À©´ó¡£6ÑÛDCPѪҺ¹à×¢Á¼ºÃÇÒ²»°éÍâ²ãÊÓÍøÄ¤µÄ½á¹¹¸Ä±ä¡£Ñо¿±íÃ÷£¬OCTA½á¹ûÏÔʾµÄÌÇÄò²¡ÊÓÍøÄ¤²¡±ä»Æ°ßÇø¹â¸ÐÊÜÆ÷ËðÉËÓëDCP²ãÃæÃ«Ï¸Ñª¹Ü´ÔÎÞ¹à×¢ÇøÓòÒ»Ö¡£Òò´Ë£¬ÔÚÌÇÄò²¡»Æ°ßȱѪʱ£¬DCP¶ÔÍâ²ãÊÓÍøÄ¤ºÍ¹â¸ÐÊÜÆ÷ϸ°ûµÄ¹©Ñõ¾ßÓзdz£ÖØÒªµÄ×÷Óᣣ¨ÖìÞÈ¨µÀ£©²¡Àý1£¬ÓÒÑÛ¡£SCPµÄѪ¹ÜÔìӰͼ£¨×óÉÏ£©£¬DCP£¨ÖÐÉÏ£©£¬ÂöÂçĤëϸѪ¹Ü£¨ÓÒÉÏ£©¡£»ÆÉ«¼ýÍ·´¦¿É¼ûÊÓÍøÄ¤Éø³öÎï¡£DCPµÄ·Å´óͼ£¨×óÏ£©£¬À¶Ïß±íʾɨÃèÏߣ¬ºìÏß±íʾѪҺÒì³£Á÷¶¯¡£Ñª¹ÜÔìÓ°ÏÔʾFAZµÄSCPºÍDCPÇøÓòëϸѪ¹ÜÃܶÈϽµ£¬Òì³£Çø´óÓÚ¦Ìm¡£ÓÒÏÂͼÂÌÏß±íʾDCPµÄ±ß½ç¡£ÓÒÏÂͼÖеĺìÏß˵Ã÷OCTµÄBɨÃèÄÚÍâºË²ãºÍÍâ²ãÊÓÍøÄ¤É«ËØÉÏÆ¤²ã½»½çÇø·´ÉäÂÊϽµÓëëϸѪ¹ÜÃܶÈϽµÒ»Ö¡£ÓÒÏÂͼÖлÆÉ«¼ýÍ·±êʾÊÓÍøÄ¤°×ɫɸ³öÔì³ÉÂöÂçĤÉÏÒõÓ°Çø£¬DCPÔìÓ°²»ÊÜÓ°Ï죬˵Ã÷Éø³öλÖô¦ÓÚDCP±ß½çÏ·½¡£PURPOSE:Toreportouterretinalstructuralchangesassociatedwithmacularcapillarynon-perfusionatthelevelofdeepcapillaryplexus(DCP)indiabeticpatients.DESIGN:Prospectiveobservationalcross-sectionalstudy.METHODS:Thestudyincluded14eyesof10patientswhowerediagnosedashavingdiabeticretinopathy.Tostudytheouterretinaandlocalizeareasofcapillarynon-perfusionatthesuperficial(SCP)orDCP,weusedthespectraldomainopticalcoherencetomography(SD-OCT)device(RTVue-XRAvanti,OptovueInc,Fremont,California)withsplit-spectrumamplitude-decorrelationangiography(SSADA)softwareforopticalcoherencetomographyangiography(OCTA).Twoindependentmaskedgraders(F.S.andA.A.F.)qualitativelyevaluatedSD-OCTscansaseithernormalorhavingouterretinadisruption.Theangiographicimageswereexaminedtodefinethepresenceandlocationofcapillarynon-perfusion.RESULTS:EighteyesshowedouterretinaldisruptiononSD-OCTthatco-localizedtoareasofenlargedfovealavascularzone,enlargedareasofnoflowbetweencapillariesandcapillarynon-perfusionoftheDCP.SixeyeswithoutouterretinalchangesonSD-OCTshowedrobustperfusionoftheDCP.CONCLUSIONS:UsingOCTA,thisstudyshowsthatmacularphotoreceptordisruptiononSD-OCTinpatientswithdiabeticretinopathycorrespondstoareasofcapillarynon-perfusionatthelevelofDCP.ThisisimportantinhighlightingthecontributionoftheDCPtotheoxygenrequirementsofthephotoreceptorsaswellastheouterretinaindiabeticmacularischemia.ÐèÒªÔÎÄÇëÁôÓÊÏäÎÂÒ½ÑÛÊÓ¹âÁÙ´²¿ÆÑÐÖÐÐÄ白癜风有什么办法治ç–?白癜风治疗去哪里
×ªÔØÇë×¢Ã÷£ºhttp://www.pdnyq.com/wmcxyf/9331.html